Las Vegas, NV -- (SBWIRE) -- 10/15/2013 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks. Our Today’s Focus is on: Zions Bancorporation (NASDAQ:ZION), Molex Incorporated (NASDAQ:MOLX), Franklin Resources, Inc. (NYSE:BEN), GlaxoSmithKline plc (ADR) (NYSE:GSK
Zions Bancorporation (NASDAQ:ZION) managed to keep its gain at 0.76% on below -normal volume of 1.45M shares. The stock settled at $28.54 after floating in a range of $27.66 to $28.62. Its latest price has reached market capitalization of $5.29 billion. Its 52-week range has been $19.03 to $31.40. Zions Bancorporation is a financial holding company. The Company focuses on providing community banking services by continuously strengthening its core business lines of small and medium-sized business and corporate banking.
For How Long ZION will fight for Profitability? Read This Trend Analysis report
Molex Incorporated (NASDAQ:MOLX) showed no change at $38.62 on a volume of 1.45 million, lower than its standard daily volume.. Over the last twelve months, the stock has gained 50.33% and faced a worst price of $24.99. Molex Incorporated is a manufacturer of electronic connectors. The Company manufactures and sells electronic components.
Is MOLX a Solid Investment at These Levels? Read This Report For Details
Franklin Resources, Inc. (NYSE:BEN) settled 0.35% higher at $51.45 on below -normal volume of 1.44M shares during the last trading day. The stock has its 12-month high at $56.54 and 52-week low price was $41.34. It traded in a range of $50.51 to $51.47 during the last trading day. Franklin Resources, Inc. (Franklin) is a holding company. Franklin together with its various subsidiaries (collectively, the Company), is referred to as Franklin Templeton Investments, is a global investment management organization offering investment choices under the Franklin, Templeton, Mutual Series, Bissett, Fiduciary and Darby brand names.
Why Should Investors Buy BEN After the Recent Fall? Just Go Here and Find Out
In the last trading session, GlaxoSmithKline plc (ADR) (NYSE:GSK) was up on low volume, trading at a volume of 1.44M shares versus its average daily volume of 2.45 million shares. At $50.35, the stock has attained market capitalization of $123.58 billion. GlaxoSmithKline plc (GSK) is global healthcare group, which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products.
Will GSK sContinue To Move Higher? Find Out Here
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)